Holen Sie sich die Stockscreener-App
22.22
8.07%
-1.95
Handel nachbörslich:
22.00
-0.22
-0.99%
Finanzdaten der Tango Therapeutics Inc-Aktie (TNGX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | 53.81 | 3.181 |
| Operating Expenses |
22.59%
59.78
|
48.77 | 41.86 | 39.74 | 44.15 |
| Operating Income/Loss |
22.59%
-59.78
|
-48.77 | -41.86 | 14.07 | -40.97 |
| Net Interest Income/Expense |
71.02%
3.723
|
2.177 | 1.68 | 1.097 | 1.239 |
| Nonoperating Income/Loss |
36.52%
4.445
|
3.256 | 3.06 | 1.802 | 2.149 |
| Income/Loss From Continuing Operations Before Tax |
21.59%
-55.34
|
-45.51 | -38.80 | 15.87 | -38.82 |
| Income Tax Expense/Benefit |
0.00%
0.001
|
0.001 | -0.055 | -0.01 | 0.035 |
| Net Income/Loss |
21.59%
-55.34
|
-45.51 | -38.75 | 15.88 | -38.85 |
| Basic Average Shares |
4.39%
149.88
|
143.58 | 5.4045 | 110.97 | 110.54 |
| Diluted Average Shares |
4.39%
149.88
|
143.58 | 5.4045 | 117.78 | 110.54 |
| Basic Earnings Per Share |
15.62%
-0.37
|
-0.32 | -0.30 | 0.14 | -0.35 |
| Diluted Earnings Per Share |
15.62%
-0.37
|
-0.32 | -0.30 | 0.13 | -0.35 |
3.28%
0.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):